Proteomic biomarkers in Gaucher disease

Area of Science:

• Biochemistry
• Proteomics
• Genetics

Background:

• Gaucher disease type 1 (GDt1) is a rare genetic disorder.
• Identifying novel biomarkers and therapeutic targets is crucial for managing GDt1.

Purpose of the Study:

• To discover new biomarkers and potential drug targets in GDt1 by analyzing serum proteins.
• To investigate differences in protein expression profiles between GDt1 patients and healthy controls.

Main Methods:

• Observational, cross-sectional study involving 12 adult participants (6 GDt1 patients, 6 healthy controls).
• Proteomics analysis of fasting venous blood samples.
• Analysis of over 400 proteins and confirmation of gene expression changes.

Main Results:

• 31 proteins showed significantly different concentrations between GDt1 patients and controls.
• Proteins involved in inflammation and hemostasis were notably altered.
• Levels of certain inflammatory markers were elevated, while humoral response proteins were decreased in GDt1 patients.

Conclusions:

• The study identified potential new targets for GDt1 diagnosis, treatment, and monitoring.
• These findings may advance clinical management strategies for Gaucher disease type 1.